Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) Short Interest Update

Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) was the target of a significant growth in short interest during the month of May. As of May 29th, there was short interest totaling 252,647 shares, a growth of 600.3% from the May 14th total of 36,079 shares. Approximately 6.2% of the shares of the stock are sold short. Based on an average trading volume of 413,217 shares, the days-to-cover ratio is presently 0.6 days.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Defiance Daily Target 2X Long LLY ETF stock. Jump Financial LLC bought a new position in shares of Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 9,186 shares of the company’s stock, valued at approximately $234,000. Jump Financial LLC owned about 0.54% of Defiance Daily Target 2X Long LLY ETF as of its most recent filing with the Securities & Exchange Commission.

Defiance Daily Target 2X Long LLY ETF Stock Performance

NYSEARCA:LLYX traded down $0.82 during mid-day trading on Friday, reaching $25.43. The stock had a trading volume of 178,617 shares, compared to its average volume of 479,751. The stock has a 50-day simple moving average of $19.83 and a two-hundred day simple moving average of $21.91. Defiance Daily Target 2X Long LLY ETF has a 12 month low of $9.60 and a 12 month high of $28.44.

About Defiance Daily Target 2X Long LLY ETF

The Defiance Daily Target 2X Long LLY ETF (LLYX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses. LLYX was launched on Aug 7, 2024 and is issued by Defiance.